DRs for IL17 can help regulate the immune response and reduce inflammation in conditions such as autoimmune diseases (e.g. rheumatoid arthritis, psoriasis), inflammatory bowel disease, and certain types of cancer. This evidence concerns the gene IL17A and rheumatoid arthritis.